Contact Info

Research Interests

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.